These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 11365895)
1. Body composition changes with protease therapy. Berger D Posit Aware; 1998; 9(5):47. PubMed ID: 11365895 [TBL] [Abstract][Full Text] [Related]
2. Fat, sugar and drugs on the French Riviera. Lands L GMHC Treat Issues; 1999 Mar; 13(3):9-11. PubMed ID: 11366205 [TBL] [Abstract][Full Text] [Related]
6. On the trail of fugitive fat: the chase turns to NRTIs. Mascolini M J Int Assoc Physicians AIDS Care; 1999 Oct; 5(10):24-43. PubMed ID: 11366871 [TBL] [Abstract][Full Text] [Related]
7. Growth hormone for protease paunch? Treat Rev; 1998; (No 28):15. PubMed ID: 11365422 [TBL] [Abstract][Full Text] [Related]
8. Are changes in body shape due to drug side effects? TreatmentUpdate; 1999 Jun; 11(4):3-4. PubMed ID: 11366790 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of treatment-induced lipid abnormalities and lipodystrophy. Smith D J HIV Ther; 2001 May; 6(2):25-7. PubMed ID: 11501199 [No Abstract] [Full Text] [Related]
10. Protease inhibitors raising quality-of-life issues for HIV patients. Silversides A CMAJ; 1999 Mar; 160(6):894. PubMed ID: 10189444 [No Abstract] [Full Text] [Related]
11. Changes in body shape and metabolic abnormalities. Res Initiat Treat Action; 1999 Jan; 5(1):18. PubMed ID: 11366225 [TBL] [Abstract][Full Text] [Related]
12. Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry. Tavassoli N; Bagheri H; Sommet A; Delpierre C; Marion-Latard F; Massip P; Aquilina C; Bonnet E; Obadia M; Labau E; Montastruc JL; Bernard J Pharmacotherapy; 2006 Feb; 26(2):154-61. PubMed ID: 16466321 [TBL] [Abstract][Full Text] [Related]
13. What is happening to my body? Rappoport C WORLD; 1999 Nov; (No 103):4-6. PubMed ID: 11366859 [TBL] [Abstract][Full Text] [Related]
14. Are changes in body shape linked to viral load. TreatmentUpdate; 1999 Jun; 11(4):4-5. PubMed ID: 11366791 [TBL] [Abstract][Full Text] [Related]
15. The next generation of human growth hormone. How Serostim and tesamorelin measure up. Grodeck B Posit Aware; 2008; 19(5):28-32. PubMed ID: 18828236 [No Abstract] [Full Text] [Related]
16. Current concepts of metabolic abnormalities in HIV patients: focus on lipodystrophy. Kolter DP AIDS Read; 2003 Dec; 13(12 Suppl):S5-13. PubMed ID: 14959694 [TBL] [Abstract][Full Text] [Related]
17. Lipodrama. Horn T Res Initiat Treat Action; 1999 Dec; 5(5):13-5. PubMed ID: 11366885 [TBL] [Abstract][Full Text] [Related]
18. Effects of sex and race on lipodystrophy pathogenesis. Nolan D; Mallal S J HIV Ther; 2001 May; 6(2):32-6. PubMed ID: 11501201 [No Abstract] [Full Text] [Related]
19. Lipodystrophy and women: a beach ball on sticks. Marcotte B Posit Aware; 2004; 15(3):14-6. PubMed ID: 15206387 [No Abstract] [Full Text] [Related]
20. HAL in 2001: a fat oddity. Grinberg L; Torres G GMHC Treat Issues; 1999 Mar; 13(3):2-5, 8. PubMed ID: 11366203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]